Introduction
The prevalence of non-alcoholic fatty liver disease (NAFLD) is greatly increased in patients with lipodystrophy and some but not all other causes of Severe Insulin Resistance (SIR). Although liver biopsy remains the definitive technique for diagnosis and staging of NAFLD, non-invasive techniques, such as magnetic resonance spectroscopy (MRS) and magnetic resonance imaging (MRI) are increasingly used to assess response to interventions such as leptin therapy. The National Severe Insulin Resistance Service is commissioned by the National Specialist Commissioning Team for patients from England with lipodystrophy and/or SIR. Selected patients attending the service, including all those receiving leptin therapy, are offered annual measurement of % liver fat using either MRS or MRI. 
Patient population

MR scanning techniques
Magnetic Resonance Spectroscopy: In 13/31 patients, % liver fat was measured using proton magnetic resonance spectroscopy on a Siemens 3T Verio MR scanner. A nonwater suppressed, respiratory gated, spectrum was obtained from a single voxel located within the posterior aspect of the right lobe of the liver (64 averages, TR = 7s). Liver fat was quantified by comparing the CH2 resonance at 1.3 ppm with water at 4.7 ppm. Magnetic Resonance Imaging: In 18/31 patients, % liver fat was measured using in-phase and out of phase gradient-echo MRI with dual flip angles of 20 and 70 degrees corrected for T2* decay. (Table 2) . However in two patients with biopsy proven fibrotic liver disease the % liver fat was unexpectedly low (4.0% and 6.0% respectively), (Figure 1b ). There were significant correlations between % liver fat and plasma bilirubin/ALT in patients receiving MRS but not MRI. There were no significant correlations between % liver fat and fasting triglycerides, HbA1c or BMI, but this is likely to be due to the relatively small number of patients (Table 3) .
Results
26/31 (84%) of patients had a liver fat of >5%
Discussion
As expected the majority (84%) of patients with lipodystrophy/ and or SIR of unknown cause had a percentage liver fat of >5%, signifying significant NAFLD in those patients. Serial MRI or MRS is useful in assessing response to interventions such as leptin therapy and dietary changes in individual patients. It is important to note however that a normal MRI or MRS % liver fat result does not exclude the presence of significant NAFLD and may even signify the presence of fibrosis in some cases, although this is yet to be formally proven. b.
